US FDA issues 'Official Action Indicated' status to Sun Pharma’s Baska facility after inspection

Sun Pharmaceutical Industries Ltd announced that its Baska manufacturing facility has been classified as Official Action Indicated (OAI) by the US FDA following a recent inspection. Despite this classification, the company confirmed that supplies to the US market from the plant will continue uninterrupted. Sun Pharma stated it will collaborate with the regulator to ensure full compliance.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7OhGSwU
via IFTTT